Company DT&CRO CO., Ltd.

Equities

A383930

KR7383930005

Healthcare Facilities & Services

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sales per region

Sector Medical & Diagnostic Laboratories

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-05-13 pm EDT			5-day change	1st Jan Change
8,790 ^KRW	+4.27%		+12.12%	-51.52%

Feb. 22	DT&CRO CO., Ltd. announced that it has received KRW 16 billion in funding from a group of investors	CI
Feb. 20	DT&CRO CO., Ltd. announced that it expects to receive KRW 16 billion in funding from a group of investors	CI

DT&CRO Co Ltd is a Korea-based company principally engaged in the contract research business. The Company is engaged in the provision of non-clinical and clinical trial services in the fields of pharmaceuticals, medical devices, food, chemicals and cosmetics. The Company is also engaged in the provision of analysis, efficacy evaluation and other services.

KRW in Million	2022	Weight	2023	Weight	Delta
Non-clinical 52.1 %	15,147	34.4 %	13,848	52.1 %	-8.58%
Analysis 24.3 %	8,006	18.2 %	6,467	24.3 %	-19.22%
Clinical 13.6 %	18,327	41.6 %	3,617	13.6 %	-80.26%
Efficacy 10.0 %	2,528	5.7 %	2,654	10.0 %	+5.02%

KRW in Million	2022	Weight	2023	Weight	Delta
South Korea 99.6 %	43,948	99.9 %	26,474	99.6 %	-39.76%
Overseas 0.4 %	60	0.1 %	112	0.4 %	+88.26%

Managers	Title	Age	Since
Chae-Kyu Park CEO	Chief Executive Officer	63	17-12-31
Su-Young Choi PSD	President	67	21-08-31
Hak-Jae Lee BRD	Director/Board Member	54	17-03-31
Deok-Sung Sun BRD	Director/Board Member	55	18-01-31
Jong-Myeong Song AUD	Comptroller/Controller/Auditor	50	22-02-28

Members of the board	Title	Age	Since
Chae-Kyu Park CEO	Chief Executive Officer	63	17-12-31
Deok-Sung Sun BRD	Director/Board Member	55	18-01-31
Hak-Jae Lee BRD	Director/Board Member	54	17-03-31
Sung-Kyu Lee BRD	Director/Board Member	51	22-05-31

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	12,770,512	7,035,100 ( 55.09 %)	0	55.09 %

Name	Equities	%	Valuation
DT&C.CO.,LTD 40.72 %	5,200,000	40.72 %	25 M ₩
Aju IB Investment Co., Ltd. (Private Equity) 4.725 %	603,368	4.725 %	3 M ₩
Chae-Kyu Park 1.378 %	176,000	1.378 %	848 100 ₩
DT&CRO Co., Ltd. ESOA 0.7011 %	89,536	0.7011 %	431 452 ₩
Jong-young Kim 0.1566 %	20,000	0.1566 %	96 375 ₩
Jeong Seong-won 0.0392 %	5,000	0.0392 %	24 094 ₩
Jeong Hyeyeon 0.0392 %	5,000	0.0392 %	24 094 ₩
Hye-yeon Jeong 0.0290 %	3,700	0.0290 %	17 829 ₩
Deok-Sung Sun 0.003923 %	501	0.003923 %	2 414 ₩

DT&CRO Co. Ltd.

28 Baengnyeong-ro 20beon-gil Cheoin-gu

17042, Yongin-si

http://www.dtncro.com

Healthcare

Healthcare Services

Healthcare Providers & Services

Healthcare Facilities & Services

Medical & Diagnostic Laboratories

	1st Jan change	Capi.
DT&CRO CO., LTD.	-51.52%	78.48M
SONIC HEALTHCARE LIMITED	-13.90%	8.58B
RADNET, INC.	+62.81%	4.12B
DR. LAL PATHLABS LIMITED	-3.34%	2.48B
SYNLAB AG	-9.81%	2.44B
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.	-43.01%	2.29B
NEOGENOMICS, INC.	-3.28%	2B
FLEURY S.A.	-18.46%	1.53B
DIAN DIAGNOSTICS GROUP CO.,LTD.	-40.24%	1.21B
METROPOLIS HEALTHCARE LIMITED	+9.42%	1.12B

Medical & Diagnostic Laboratories